U.S. Right to Know

Pharma bribery corrupts health care, puts patients at risk, new review warns

Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.

Read the original at U.S. Right to Know

More audio from U.S. Right to Know